Vancomycin Dosing Calculator

Vancomycin is a large glycopeptide that is cleared almost entirely unchanged by glomerular filtration, so its elimination rate constant tracks creatinine clearance closely; the linear relation used here, ke equal to 0.00083 x CrCl plus 0.0044 per hour, gives a half-life of about 6 to 9 hours at a clearance of 90 to 120 mL/min and more than 24 hours below 30 mL/min. That is why the loading dose and the maintenance interval are decided separately. A load of 25 to 30 mg/kg of actual body weight fills a volume of distribution of roughly 0.7 L/kg regardless of kidney function, while the interval - every 8, 12, 24, 48, or 72 hours - is chosen purely from estimated clearance. Maintenance doses of 15 to 20 mg/kg are rounded to the nearest 250 mg because vials and infusion practice work in those increments. The modern pharmacodynamic target is the ratio of the 24-hour area under the curve to the minimum inhibitory concentration, with a window of 400 to 600 mg times hour per litre assuming an MIC of 1 mg/L; below 400 treatment failure in Staphylococcus aureus bacteraemia rises, and above 600 acute kidney injury rises sharply. Cockcroft-Gault is an estimate, not a measurement, and it misleads in the two directions that matter most: it overstates clearance in the sarcopenic elderly with low creatinine production and understates it in young patients with augmented renal clearance. Obesity, unstable creatinine, dialysis, and concurrent piperacillin-tazobactam all break the assumptions, and any calculated regimen should be re-derived from measured levels once the patient is at steady state.

Vancomycin came out of a soil sample sent from Borneo to Eli Lilly in the early 1950s, where the chemist Edmund Kornfeld isolated an antibacterial compound from the organism then called Streptomyces orientalis and now classified as Amycolatopsis orientalis. Named from the word vanquish, it was pushed rapidly to market and licensed in 1958 as one of the few options against penicillin-resistant staphylococci. The early product was brown and impure enough to be nicknamed Mississippi mud, and the nephrotoxicity and ototoxicity attributed to it in that era were probably driven as much by the fermentation impurities as by the drug. Purification improved through the 1960s and 1970s, but by then methicillin and the cephalosporins had largely displaced it. Its revival came with hospital-acquired methicillin-resistant Staphylococcus aureus in the 1980s, which returned vancomycin to first-line status and forced attention to dosing. Weight-based methods borrowed the ideal body weight formula published by B. J. Devine in 1974 and the creatinine clearance equation published by Donald Cockcroft and Henry Gault in 1976. A 2009 consensus statement from ASHP, IDSA, and SIDP recommended targeting troughs of 15 to 20 mcg/mL for serious infection, but accumulating evidence linked those troughs to acute kidney injury without added benefit. The revised 2020 consensus guideline, led by Michael Rybak, formally moved practice to AUC-guided monitoring, and Bayesian dose-optimisation software has since become common in hospital pharmacy.